United Services Automobile Association’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-86,296
Closed -$271K – 2189
2019
Q2
$271K Buy
86,296
+5,273
+7% +$17.1K ﹤0.01% 1919
2019
Q1
$301K Sell
81,023
-8,553
-10% -$28.9K ﹤0.01% 1898
2018
Q4
$260K Buy
89,576
+10,354
+13% +$28.4K ﹤0.01% 1889
2018
Q3
$208K Buy
79,222
+11,010
+16% +$27K ﹤0.01% 2136
2018
Q2
$160K Buy
68,212
+21,899
+47% +$61.1K ﹤0.01% 2169
2018
Q1
$136K Buy
46,313
+33,002
+248% +$90.1K ﹤0.01% 2144
2017
Q4
$36K Buy
+13,311
New +$40.9K ﹤0.01% 1456

Other funds holding PDLI

United Services Automobile Association's PDLI Position: Q3 2019 in Review

United Services Automobile Association sold out of PDL BioPharma, Inc. (PDLI) in Q3 2019, closing a stake of 86,296 shares — an estimated $271K sold.

United Services Automobile Association first reported a position in PDLI in Q4 2017 and held it in 7 quarters. The position peaked at $301K in Q1 2019. 140 funds tracked by Wall St. Rank hold PDLI as of Q3 2019.

  • United Services Automobile Association reported no remaining PDL BioPharma, Inc. position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 86,296 PDL BioPharma, Inc. shares in Q3 2019, an estimated $271K.
  • United Services Automobile Association first reported a position in PDL BioPharma, Inc. in Q4 2017 and held it in 7 quarters.
  • United Services Automobile Association's PDL BioPharma, Inc. position peaked at $301K in Q1 2019.
  • 140 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.